(Q36659821)

15 August 2017

1 reference

title

A systematic review on drug interactions in oncology (English)

1 reference

15 August 2017

1 reference

Rachel P Riechelmann

1

1 reference

15 August 2017

Everardo D Saad

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

24

1 reference

15 August 2017

issue

7

1 reference

15 August 2017

page(s)

704-712

1 reference

Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Understanding and preventing drug interactions in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Prospective evaluation of adverse drug interactions in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Bicalutamide: clinical pharmacokinetics and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Pharmacokinetics of third-generation aromatase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Gefitinib, a novel, orally administered agent for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Fatal adverse drug events: the paradox of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Proton pump inhibitors and their drug interactions: an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Antidepressant interactions with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Determination of drug interactions occurring with the metabolic pathways of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Modulation of irinotecan metabolism by ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Decreased phenytoin levels in patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

The influence of cimetidine on the pharmacokinetics of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) in patients with different gastroenteric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Benzodiazepine mediated antagonism of opioid analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Antinociceptive interaction between alprazolam and opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Clinical cardiac tolerability of trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

An adverse interaction between warfarin and 5-fluorouracil: A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Adverse interaction between capecitabine and warfarin resulting in altered coagulation parameters and bleeding: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Diminished anticoagulant effects of warfarin with concomitant mercaptopurine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Life threatening interaction between tamoxifen and warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Tamoxifen-warfarin interaction: the Aberdeen hospitals drug file

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Protease inhibitors potentiate chemotherapy-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Pharmacokinetic drug interactions of commonly used anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Pharmacokinetic drug interactions with anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Phase I and pharmacokinetic trial of carboplatin in refractory adult leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Loss of analgesic effect of morphine due to coadministration of rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Phenytoin and fluorouracil interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

An adverse interaction between warfarin and capecitabine: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Rescue after intermediate and high-dose methotrexate: background, rationale, and current practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

The effect of metoclopramide on the absorption of oral controlled release morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900601063766

10.1080/07357900601063766

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference